Related Experiment Video
Updated: May 17, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
The Alzheimer's disease-associated TREM2 gene is regulated by p53 tumor suppressor protein
Artur Zajkowicz1, Agnieszka Gdowicz-Kłosok1, Małgorzata Krześniak1
1Center for Translational Research and Molecular Biology of Cancer, Maria Skłodowska-Curie Institute-Oncology Center, Gliwice Branch, 44-101 Gliwice, Poland.
Abstract:
TREM2 mutations evoke neurodegenerative disorders, and recently genetic variants of this gene were correlated to increased risk of Alzheimer's disease. The signaling cascade originating from the TREM2 membrane receptor includes its binding partner TYROBP, BLNK adapter protein, and SYK kinase, which can be activated by p53. Moreover, in silico identification of a putative p53 response element (RE) at the TREM2 promoter led us to hypothesize that TREM2 and other pathway elements may be regulated in p53-dependent manner. To stimulate p53 in synergistic fashion, we exposed A549 lung cancer cells to actinomycin D and nutlin-3a (A + N). In these cells, exposure to A + N triggered expression of TREM2, TYROBP, SYK and BLNK in p53-dependent manner. TREM2 was also activated by A + N in U-2 OS osteosarcoma and A375 melanoma cell lines. Interestingly, nutlin-3a, a specific activator of p53, acting alone stimulated TREM2 in U-2 OS cells. Using in vitro mutagenesis, chromatin immunoprecipitation, and luciferase reporter assays, we confirmed the presence of the p53 RE in TREM2 promoter. Furthermore, activation of TREM2 and TYROBP by p53 was strongly inhibited by CHIR-98014, a potent and specific inhibitor of glycogen synthase kinase-3 (GSK-3). We conclude that TREM2 is a direct p53-target gene, and that activation of TREM2 by A + N or nutlin-3a may be critically dependent on GSK-3 function.
Insights
The study reveals that TREM2 is a direct target gene of p53. This discovery sheds light on the p53-dependent regulation of TREM2 and its pathway, potentially impacting neurodegenerative disorders like Alzheimer's disease.
Area of Science:
- Molecular Biology
- Neuroscience
- Genetics
Background:
- TREM2 mutations are linked to neurodegenerative disorders and increased Alzheimer's disease risk.
- The TREM2 signaling pathway involves TYROBP, BLNK, and SYK, with p53 potentially regulating this cascade.
- A putative p53 response element (RE) in the TREM2 promoter suggests p53-dependent regulation.
Purpose of the Study:
- To investigate if TREM2 and its associated pathway genes are regulated by p53.
- To confirm the functional role of the identified p53 RE in the TREM2 promoter.
- To elucidate the mechanism of p53-mediated TREM2 activation.
Main Methods:
- Stimulation of p53 using actinomycin D and nutlin-3a (A+N) in lung cancer cells (A549).
- Analysis of TREM2, TYROBP, SYK, and BLNK expression in various cell lines (A549, U-2 OS, A375).
- In vitro mutagenesis, chromatin immunoprecipitation, and luciferase reporter assays to validate p53 RE function.
- Inhibition studies using glycogen synthase kinase-3 (GSK-3) inhibitor CHIR-98014.
Main Results:
- Exposure to A+N induced TREM2, TYROBP, SYK, and BLNK expression in a p53-dependent manner in A549 cells.
- TREM2 activation by A+N was observed in osteosarcoma (U-2 OS) and melanoma (A375) cells.
- Nutlin-3a alone stimulated TREM2 in U-2 OS cells, confirming p53's role.
- The p53 RE was confirmed in the TREM2 promoter, demonstrating direct p53 binding.
- p53-mediated activation of TREM2 and TYROBP was significantly inhibited by GSK-3 inhibitor CHIR-98014.
Conclusions:
- TREM2 is identified as a direct p53-target gene.
- The activation of TREM2 by p53 activators (A+N or nutlin-3a) is critically dependent on glycogen synthase kinase-3 (GSK-3) function.
- These findings provide new insights into the molecular mechanisms regulating TREM2 and its potential role in disease.
Related Concept Videos
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
DNA Damage can Stall the Cell Cycle
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

